Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

YAP mediates the positive regulation of hnRNPK on the lung adenocarcinoma H1299 cell growth.

Xu L, Zhang T, Huang W, Liu X, Lu J, Gao X, Zhang YF, Liu L.

Acta Biochim Biophys Sin (Shanghai). 2019 Jul 10;51(7):677-687. doi: 10.1093/abbs/gmz053.

PMID:
31187136
2.

Regulation and related mechanism of GSN mRNA level by hnRNPK in lung adenocarcinoma cells.

Liu XH, Ma J, Feng JX, Feng Y, Zhang YF, Liu LX.

Biol Chem. 2019 Jun 26;400(7):951-963. doi: 10.1515/hsz-2018-0417.

PMID:
30771276
3.

ERK1/2-mediated Cytoplasmic Accumulation of hnRNPK Antagonizes TRAIL-induced Apoptosis through Upregulation of XIAP in H1299 Cells.

Huang WS, Xu FM, Zeng QZ, Liu XH, Gao XJ, Liu LX.

Biomed Environ Sci. 2017 Jul;30(7):473-481. doi: 10.3967/bes2017.063.

4.

Inhibition of CXCR4 regulates epithelial mesenchymal transition of NSCLC via the Hippo-YAP signaling pathway.

Zheng CH, Chen XM, Zhang FB, Zhao C, Tu SS.

Cell Biol Int. 2018 Sep;42(10):1386-1394. doi: 10.1002/cbin.11024. Epub 2018 Jul 17.

PMID:
29972256
5.

Inhibition of ERK1/2 down-regulates the Hippo/YAP signaling pathway in human NSCLC cells.

You B, Yang YL, Xu Z, Dai Y, Liu S, Mao JH, Tetsu O, Li H, Jablons DM, You L.

Oncotarget. 2015 Feb 28;6(6):4357-68.

6.

hnRNPK inhibits GSK3β Ser9 phosphorylation, thereby stabilizing c-FLIP and contributes to TRAIL resistance in H1299 lung adenocarcinoma cells.

Gao X, Feng J, He Y, Xu F, Fan X, Huang W, Xiong H, Liu Q, Liu W, Liu X, Sun X, He QY, Zhang Q, Liu L.

Sci Rep. 2016 Mar 14;6:22999. doi: 10.1038/srep22999.

7.

YAP regulates PD-L1 expression in human NSCLC cells.

Miao J, Hsu PC, Yang YL, Xu Z, Dai Y, Wang Y, Chan G, Huang Z, Hu B, Li H, Jablons DM, You L.

Oncotarget. 2017 Dec 9;8(70):114576-114587. doi: 10.18632/oncotarget.23051. eCollection 2017 Dec 29.

8.

Heterogeneous nuclear ribonucleoprotein K is associated with poor prognosis and regulates proliferation and apoptosis in bladder cancer.

Chen X, Gu P, Xie R, Han J, Liu H, Wang B, Xie W, Xie W, Zhong G, Chen C, Xie S, Jiang N, Lin T, Huang J.

J Cell Mol Med. 2017 Jul;21(7):1266-1279. doi: 10.1111/jcmm.12999. Epub 2016 Nov 10.

9.

PDK-1 mediated Hippo-YAP-IRS2 signaling pathway and involved in the apoptosis of non-small cell lung cancer cells.

Wang G, Liu X, Xie J, Meng J, Ni X.

Biosci Rep. 2019 May 14;39(5). pii: BSR20182099. doi: 10.1042/BSR20182099. Print 2019 May 31.

10.

Expression of Yes-associated protein in non-small cell lung cancer and its relationship with clinical pathological factors.

Su LL, Ma WX, Yuan JF, Shao Y, Xiao W, Jiang SJ.

Chin Med J (Engl). 2012 Nov;125(22):4003-8.

PMID:
23158133
11.

TNFAIP8 regulates Hippo pathway through interacting with LATS1 to promote cell proliferation and invasion in lung cancer.

Han Y, Tang Z, Zhao Y, Li Q, Wang E.

Mol Carcinog. 2018 Feb;57(2):159-166. doi: 10.1002/mc.22740. Epub 2017 Dec 5.

PMID:
28926138
12.

Fascin 1 promoted the growth and migration of non-small cell lung cancer cells by activating YAP/TEAD signaling.

Liang Z, Wang Y, Shen Z, Teng X, Li X, Li C, Wu W, Zhou Z, Wang Z.

Tumour Biol. 2016 Aug;37(8):10909-15. doi: 10.1007/s13277-016-4934-0. Epub 2016 Feb 17.

PMID:
26886283
13.

Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP/TAZ.

Noto A, De Vitis C, Pisanu ME, Roscilli G, Ricci G, Catizone A, Sorrentino G, Chianese G, Taglialatela-Scafati O, Trisciuoglio D, Del Bufalo D, Di Martile M, Di Napoli A, Ruco L, Costantini S, Jakopin Z, Budillon A, Melino G, Del Sal G, Ciliberto G, Mancini R.

Oncogene. 2017 Aug 10;36(32):4573-4584. doi: 10.1038/onc.2017.75. Epub 2017 Apr 3. Erratum in: Oncogene. 2017 Jun 19;:.

PMID:
28368399
14.

Hippo effector YAP directly regulates the expression of PD-L1 transcripts in EGFR-TKI-resistant lung adenocarcinoma.

Lee BS, Park DI, Lee DH, Lee JE, Yeo MK, Park YH, Lim DS, Choi W, Lee DH, Yoo G, Kim HB, Kang D, Moon JY, Jung SS, Kim JO, Cho SY, Park HS, Chung C.

Biochem Biophys Res Commun. 2017 Sep 16;491(2):493-499. doi: 10.1016/j.bbrc.2017.07.007. Epub 2017 Jul 3.

PMID:
28684311
15.

HnRNPK/miR-223/FBXW7 feedback cascade promotes pancreatic cancer cell growth and invasion.

He D, Huang C, Zhou Q, Liu D, Xiong L, Xiang H, Ma G, Zhang Z.

Oncotarget. 2017 Mar 21;8(12):20165-20178. doi: 10.18632/oncotarget.15529.

16.
17.

Stiehopus japonieus acidic mucopolysaccharide inhibits the proliferation of pancreatic cancer SW1990 cells through Hippo-YAP pathway.

Li X, Liu Y, Zhang C, Niu Q, Wang H, Che C, Xie M, Zhou B, Xu Y, Zhang Q, Wu J, Tian Z.

Oncotarget. 2017 Mar 7;8(10):16356-16366. doi: 10.18632/oncotarget.14633.

18.

Regulation of PLK1 through competition between hnRNPK, miR-149-3p and miR-193b-5p.

Shin CH, Lee H, Kim HR, Choi KH, Joung JG, Kim HH.

Cell Death Differ. 2017 Nov;24(11):1861-1871. doi: 10.1038/cdd.2017.106. Epub 2017 Jul 14.

19.

E-cadherin mediates contact inhibition of proliferation through Hippo signaling-pathway components.

Kim NG, Koh E, Chen X, Gumbiner BM.

Proc Natl Acad Sci U S A. 2011 Jul 19;108(29):11930-5. doi: 10.1073/pnas.1103345108. Epub 2011 Jul 5.

20.

YAP promotes erlotinib resistance in human non-small cell lung cancer cells.

Hsu PC, You B, Yang YL, Zhang WQ, Wang YC, Xu Z, Dai Y, Liu S, Yang CT, Li H, Hu B, Jablons DM, You L.

Oncotarget. 2016 Aug 9;7(32):51922-51933. doi: 10.18632/oncotarget.10458.

Supplemental Content

Support Center